Urinary Bladder – Talk Bio

J&J reports durability data for bladder cancer ‘pretzel’ drug after FDA filing

3 months ago talkbio0Tagged Malignant neoplasm of urinary bladder, TAR 200, United States Food and Drug Administration, Urinary Bladder

Urinary Bladder, TAR 200, United States Food and Drug Administration, Malignant neoplasm of urinary bladder

Breakthroughs in Bladder Cancer Treatment: Protara and CG Oncology Report Encouraging Outcomes

8 months ago talkbio0Tagged Carcinoma of urinary bladder, invasive, Cell Therapy, centigram, Cretostimogene Grenadenorepvec, Lyophilized Inactivated Group A Streptococcus TARA-002, Malignant Neoplasms, Neoplasms, Non-Muscle, Non-Muscle Invasive Bladder Neoplasms, Oncolytic Immunotherapy, Protara Therapeutics, Urinary Bladder

Bladder Cancer Treatment, Protara Therapeutics, CG Oncology, TARA-002, Cretostimogene Grenadenorepvec, Non-Muscle Invasive Bladder Cancer (NMIBC), Oncolytic Immunotherapy, Cell Therapy

ImmunityBio Trims Workforce Despite Recent FDA Approval for Anktiva

11 months ago talkbio0Tagged Anktiva, Approved, Cancer Therapeutic Procedure, Financial Stress, ImmunityBio, United States Food and Drug Administration, Urinary Bladder

ImmunityBio, Anktiva, FDA approval, layoffs, financial challenges, bladder cancer treatment